Publications

Title

Author

Year

Towards improving the quality and usefulness of GBD tuberculosis estimates.

WHITE, RG; Rao, JP;

2024

The Lancet. Infectious diseases, (2024).24 7 10.1016/s1473-3099(24)00079-3.

Comparative safety and effectiveness of Pfizer BA.4-5 versus Sanofi during the spring 2023 COVID-19 booster vaccination programme in England: a matched cohort study in OpenSAFELY-TPP.

Andrews, C; PRESTIGE, E; PARKER, EP K; Walker, V; Palmer, T; Schaffer, A; Green, AC A; Curtis, H; Walker, A; Smith, R; Wood, C; Bates, C; Mehrkar, A; MacKenna, B; Bacon, SC J; GOLDACRE, B; Hernán, M; Sterne, JA C; The OpenSAFELY collaborative,; Hulme, W;

2024

medRxiv (2024). 10.1101/2024.03.15.24304277.

Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.

Hartner, A-M; Li, X; Echeverria-Londono, S; Roth, J; ABBAS, K; AUZENBERGS, M; De Villiers, MJ; Ferrari, MJ; Fraser, K; FU, H; Hallett, T; Hinsley, W; JIT, M; Karachaliou, A; Moore, SM; Nayagam, S; Papadopoulos, T; Perkins, TA; Portnoy, A; Minh, QT; VYNNYCKY, E; Winter, AK; Burrows, H; CHEN, C; Clapham, HE; ... Gaythorpe, KA M.

2024

The Lancet Global health, (2024).12 4 10.1016/S2214-109X(23)00603-4.

Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.

ABBAS, K; Yoo, KJ; PREM, K; JIT, M;

2024

eClinicalMedicine, (2024).70, 10.1016/j.eclinm.2024.102524.

Systematic review of social determinants of childhood immunisation in low- and middle-income countries and equity impact analysis of childhood vaccination coverage in Nigeria.

Williams, SV; Akande, T; ABBAS, K;

2024

PLoS One, (2024).19 3 10.1371/journal.pone.0297326.

Factors Influencing Childhood Influenza Vaccination: A Systematic Review.

Han, K; Hou, Z; Tu, S; Liu, M; CHANTLER, T; LARSON, H;

2024

Vaccines, (2024).12 3 10.3390/vaccines12030233.

Safe in pregnancy: A global living systematic review and meta-analysis of COVID-19 vaccines in pregnancy.

Buekens, P; Berrueta, M; Ciapponi, A; Bardach, A; Mazzoni, A; Rodriguez-Cairoli, F; Gottlieb, SL; KAMPMANN, B; PARKER, EP K; Xiong, X; Zaraa, S; Stergachis, A;

2024

Vaccine, (2024).42 7 10.1016/j.vaccine.2024.02.012.

Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study.

KANG, H; AUZENBERGS, M; Clapham, H; Maure, C; Kim, J-H; Salje, H; Taylor, CG; LIM, A; CLARK, A; EDMUNDS, WJ; Sahastrabuddhe, S; BRADY, OJ; ABBAS, K;

2024

The Lancet Infectious Diseases, (2024).24 5 10.1016/S1473-3099(23)00810-1.

Modelling the health and economic impacts ofM72/AS01E vaccination and BCG-revaccination: Estimates for South Africa.

SUMNER, T; CLARK, RA; Mukandavire, C; Portnoy, A; Weerasuriya, CK; Bakker, R; Scarponi, D; Hatherill, M; Menzies, NA; WHITE, RG;

2024

Vaccine, (2024).42 6 10.1016/j.vaccine.2024.01.072.

What is next for BCG revaccination to prevent tuberculosis?.

WHITE, RG; Fiore-Gartland, AJ; Hanekom, WA; Vekemans, J; Garcia-Basteiro, AL; Churchyard, G; Rangaka, MX; Frick, M; Behr, MA; Hill, PC; Mave, V;